Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.

Joseph Panoff; M. Granger; G. Yanik; A. Naranjo; J. McCune; S. DuBois; R. Bagatell; B. Weiss; S. Grupp; S. Tenney; S. Asgharzadeh; M. Hogarty; J. Chang; J. Gastier-Foster; D. Mills; J. Park

Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.

Joseph Panoff, M. Granger, G. Yanik, A. Naranjo, J. McCune, S. DuBois, R. Bagatell, B. Weiss, S. Grupp, S. Tenney, S. Asgharzadeh, M. Hogarty, J. Chang, J. Gastier-Foster, D. Mills, J. Park

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - 2016
Event	ASCO 2016 - Duration: Jan 1 2016 → …

Conference

Conference	ASCO 2016
Period	1/1/16 → …

Disciplines

Medicine and Health Sciences

Cite this

Panoff, J., Granger, M., Yanik, G., Naranjo, A., McCune, J., DuBois, S., Bagatell, R., Weiss, B., Grupp, S., Tenney, S., Asgharzadeh, S., Hogarty, M., Chang, J., Gastier-Foster, J., Mills, D., & Park, J. (2016). Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.. ASCO 2016.

Panoff, J, Granger, M, Yanik, G, Naranjo, A, McCune, J, DuBois, S, Bagatell, R, Weiss, B, Grupp, S, Tenney, S, Asgharzadeh, S, Hogarty, M, Chang, J, Gastier-Foster, J, Mills, D & Park, J 2016, 'Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.', ASCO 2016, 1/1/16.

@conference{5150371818444833bbddd287791eac4f,

title = "Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children{\textquoteright}s Oncology Group (COG) study.",

author = "Joseph Panoff and M. Granger and G. Yanik and A. Naranjo and J. McCune and S. DuBois and R. Bagatell and B. Weiss and S. Grupp and S. Tenney and S. Asgharzadeh and M. Hogarty and J. Chang and J. Gastier-Foster and D. Mills and J. Park",

year = "2016",

language = "American English",

note = "ASCO 2016 ; Conference date: 01-01-2016",

}

TY - CONF

T1 - Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.

AU - Panoff, Joseph

AU - Granger, M.

AU - Yanik, G.

AU - Naranjo, A.

AU - McCune, J.

AU - DuBois, S.

AU - Bagatell, R.

AU - Weiss, B.

AU - Grupp, S.

AU - Tenney, S.

AU - Asgharzadeh, S.

AU - Hogarty, M.

AU - Chang, J.

AU - Gastier-Foster, J.

AU - Mills, D.

AU - Park, J.

PY - 2016

Y1 - 2016

M3 - Presentation

T2 - ASCO 2016

Y2 - 1 January 2016

ER -